Divi's Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company's board declared a dividend of Rs 30 per share and (...)
Site référencé: The Economic Times
The Economic Times
Sebi threatens 2 offshore funds holding Adani shares with penalties : Reports
19/05/2025
China asks US to maintain stability of international financial system after Moody's downgrade
19/05/2025
China 'fully' respects Denmark's sovereignty on Greenland, foreign minister says
19/05/2025
Muted growth, excess supply keep cement sector outlook tepid : Sandip Sabharwal
19/05/2025
Railways PSU ETF delivers 16% in a week. Is this the right opportunity for portfolio diversification ?
19/05/2025
Markets look directionally positive despite global noise : Sandip Sabharwal
19/05/2025
